Cellbyte

Cellbyte is an AI platform for pharmaceutical pricing and market access teams. It replaces weeks of manual desk research with plain language questions answered across markets, with every output traceable to its source line. The platform sits on a proprietary database of clinical, regulatory, health technology assessment and pricing data, which the vendor describes as more than 100 sources and over 30 million data points. Listed use cases include analog research for precedent assets, disease landscaping and opportunity assessment, competitive intelligence, HTA and pricing research, price evolution and comparison, comparator and endpoint assessment, launch sequence analysis, outcomes validation and treatment cost calculation. Recurring workflows can be automated, and results are shared in one workspace. Cellbyte offers two ways to work with it. The Platform gives analysts direct access to the AI agents and data. The Services option has life sciences experts combine domain knowledge with applied AI to deliver sourced evidence reviews and recommendations in days. The company was founded by Felix Steinbrenner, Daniel Moreira and Samuel Moreira, and its site includes a case study on German HTA added benefit outcomes with Lilly Deutschland. The audience is pricing, market access and launch teams at pharmaceutical manufacturers. The vendor does not publish prices and directs prospective customers to book a demo.